Jump to navigation

South Africa

Experts and activists demand more generous vaccine waivers

Over a year after India and South Africa called for emergency measures, WTO members have proposed a plan to waive patents on COVID-19 vaccines

Pressure is building on President Cyril Ramaphosa to reject a compromise proposal offered by the United States and the European Union for a temporary waiver of intellectual property (IP) on Covid-19 vaccines (AC Vol 63 No 7, Vaccine patent negotiators agree compromise formula).

Over 300 civic activists, trades unions, academics, and experts from across the world, including economics laureate Joseph Stiglitz wrote to India's Prime Minister Narendra Modi and Ramaphosa describing the leaked text on IP waivers 'inadequate' and 'a step backwards from an already untenable status quo.'

It is almost 18 months since India and South Africa asked the World Trade Organization to waive IP rights for medicines in the hope of aiding the 'prevention, containment and treatment of Covid-19'.

South African and Indian officials joined the talks that led to the compromise text prepared by the US and EU, but Ramaphosa and his ministers are yet to comment on its contents.

The leaked text proposes that the waiver would cover IP rights only on vaccines but not on treatments for Covid-19. It also states that, within six months of a final agreement, WTO members must decide on whether to extend it to include Covid-19 diagnostics and therapeutics as well. For the moment, there is no timetable for a full WTO meeting to approve or reject the plan. It would require consensus support.

It also suggested that the agreement would be restricted to five years. The waiver would apply to those WTO members that exported less than 10% of the world's vaccine doses in 2021; that provision would mean the EU, China, and the US could not benefit from the waiver.

The proposal, despite its modesty, is opposed by the pharmaceutical conglomerates. The European Federation of Pharmaceutical Industries and Associations (EFPIA) called 'on governments across Europe and around the world to urgently rethink discussions on a Covid vaccine waiver and instead focus on the real barriers to global vaccine equity'.



Related Articles

DISPATCHES

Vaccine patent negotiators agree compromise formula

World Trade Organization chief Okonjo-Iweala applauds progress but warns of struggle to convince all members states to back it

The lead team of negotiators has agreed a compromise on patents waiver over three to five years for Covid-19 vaccines which will require ratification by all WTO members....

READ FOR FREE

Battle of the plans

Rival ideas and personalities obstruct a promised plan for growth and the President will not pick a winner between the ideological factions

Jacob Zuma notched up a success when the Hawks, the special crime investigation unit, abandoned its inquiries into the arms deal in which it had been alleged that...


An awkward embrace

The ovation given to Deputy President Jacob Zuma at last month's national conference of the Congress of South African Trade Unions points again to the very odd nature...


Down to work

President Mbeki's new team is better equipped and coordinated - they'll need to be

The first real post-apartheid government will start work after President Thabo Mbeki opens parliament on 4 February, focusing at last on economic and administrative reform, rather than on...


Inevitable victory

As the challenges to the governing ANC fizzle out, people are asking what Jacob Zuma wants to do with power

There remains one main unanswered question about the elections due on 22 April : the size of the African National Congress’s vote. Most estimates put it at 55-65%...